Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium
Yana Pikman(Broad Institute), Kimberly Stegmaier(Broad Institute)
Cited by 40
Related Papers
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
|Nature Genetics|2004|269
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
|Journal of Clinical Investigation|2017|159
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
|Journal of Clinical Investigation|2012|104